 SAN DIEGO , Nov. 18, 2022 PRNewswire -- Inhibrx, Inc. Nasdaq: INBX, a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, today announced it will be presenting at the following upcoming virtual investor conference: The Evercore ISI 5th Annual HealthCONx Conference Wednesday, November 30 th at 8:45 a.m. Pacific Time The investor conference presentation will be webcast live for at least 60 days following the event and will be accessible through a link on the investors section of Inhibrxs website at 